Gwangju
South Korea
5
2020-08-20
4
2023-09-19
These are the the leading inventors for applications assigned to BETHPHAGEN INC.:
BETHPHAGEN INC. based in Gwangju, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutical composition for preventing or treating cardiac arrhythmia
#2 | 2020-07-30 ✅ Patent 12,215,362 granted on 2025-02-04Pharmaceutical composition for prevention or treatment of heart failure
#3 | 2019-10-31 ✅ Patent 11,426,441 granted on 2022-08-30Composition comprising protein phosphatase 1 inhibitory peptide for treating vascular diseases
#4 | 2019-04-18 ✅ Patent 10,479,816 granted on 2019-11-19Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban
#5 | 2018-12-27PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CARDIAC FIBROSIS
Also check out BethphaGen Inc.'s (Gwangju, South Korea) applicant profile with 4 patent applications submitted.
143200 ⎘